Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression

Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression

While 68Gallium prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA) has demonstrated increasing utility in the evaluation of prostatic carcinoma, it is essential to be aware of false-negative findings. Further subtype analyses of prostate cancer will be he...

Full description

Bibliographic Details
Main Authors:	Tansel Cakir, Selcuk Guven, Bahar Muezzinoglu, Cengiz Erol, Mustafa Yucel Boz, Tamer Atasever
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-01-01
Series:	Urology Annals
Subjects:	18F-labeled fluoro-2-deoxyglucose positron emission tomography/computed tomography 68gallium prostate-specific membrane antigen positron emission tomography/computed tomography multiparametric magnetic resonance imaging prostate cancer
Online Access:	http://www.urologyannals.com/article.asp?issn=0974-7796;year=2019;volume=11;issue=4;spage=439;epage=442;aulast=Cakir

Similar Items

Differential diagnosis of relapsing polychondritis from asthma by 18‐fluoro‐2‐deoxyglucose positron emission tomography and computed tomography
by: Mariko Ono, et al.
Published: (2021-04-01)

Intense focal Fluoro-deoxyglucose uptake in the lungs with no corresponding computed tomography abnormality
by: Ameya D Puranik, et al.
Published: (2013-01-01)

Performance of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography in the diagnosis of primary prostate cancer: a systematic review and meta-analysis
by: Xianwen Hu, et al.
Published: (2022-11-01)

Dynamic 11C-Choline PET / CT for the primary diagnosis of prostate cancer
by: Shay Golan, et al.

Identification of the Optimal Cut-Off Value of PSA for Assessing Severity of Disease in [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT Study in Prostate Cancer Patients after Radical Prostatectomy
by: Paulina Cegla, et al.
Published: (2022-01-01)

Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients
by: Ioana M. Marinescu, et al.
Published: (2022-07-01)

Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
by: Álan Roger Gomes Barbosa, et al.
Published: (2022-05-01)

Value of 18F-PSMA PET/MRI for early diagnosis of recurrence and metastasis in prostate cancer patients after radical prostatectomy
by: ZHOU Yilei, ZHANG Miao, GUO Rui, ZHOU Jinxin, LI Biao, LI Xiang
Published: (2023-12-01)

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?
by: Jianliang Liu, et al.
Published: (2024-01-01)

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
by: Mei Li, et al.
Published: (2022-10-01)

Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases
by: Yinjie Zhu, et al.
Published: (2019-07-01)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer
by: Nuno Dias, et al.
Published: (2022-12-01)

Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer
by: Yiyan Liu
Published: (2013-09-01)

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2024-01-01)

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions
by: Sebastian Meißner, et al.
Published: (2017-10-01)

Value of 11C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
by: Shuoming Zhou, et al.
Published: (2021-02-01)

Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed
by: Sofia Santos-Lopes, et al.
Published: (2017-01-01)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
by: Joris G. Heetman, et al.
Published: (2022-10-01)

The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence
by: Jie Jiang, et al.
Published: (2022-05-01)

11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
by: Kazuhiro Kitajima, et al.
Published: (2016-11-01)

A Review of Modern Imaging Landscape for Prostate Cancer: A Comprehensive Clinical Guide
by: Paul Gravestock, et al.
Published: (2023-02-01)

Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis
by: Sui Wai Ling, et al.
Published: (2021-11-01)

Correlation between 18F⁃S16 PET imaging and glucose metabolism pattern in behavioral variant frontotemporal dementia
by: WANG Ying, et al.
Published: (2022-12-01)

Restaging the Biochemical Recurrence of Prostate Cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
by: Aloÿse Fourquet, et al.
Published: (2021-03-01)

Breathing-induced Errors in Quantification and Description of Dominant Intra-Prostatic Lesions (Dils) in PET Images: A Simulation Study by Means of The 4D NCAT Phantom
by: Khadijeh Bamneshin, et al.
Published: (2022-10-01)

Primary spindle cell sarcoma of the prostate and 18 F-fluorodeoxyglucose-positron-emission tomography/computed tomography findings
by: Hakan Öztürk
Published: (2015-01-01)

F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review
by: Schröer-Günther Milly A, et al.
Published: (2012-12-01)

Predictive value of Dmax and %ΔSUVmax of 18F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
by: Jun Dang, et al.
Published: (2023-10-01)

Prostate MRI and PSMA-PET in the Primary Diagnosis of Prostate Cancer
by: Lorenzo Cereser, et al.
Published: (2023-08-01)

Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab
by: Tadashi Tabei, et al.
Published: (2019-04-01)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
by: Ellen O'Connor, et al.
Published: (2020-11-01)

Atypical Uptake of 18<sup>F</sup>DG in White Adipose Tissue During PET/CT in Children
by: M. M. Dunaikin, et al.
Published: (2023-08-01)

Frequency and Clinical Significance of Incidental Prostatic FDG uptake in FDG PET imaging
by: Elif Özdemir, et al.
Published: (2020-06-01)

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer
by: YANG Liping, et al.
Published: (2018-07-01)

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer
by: Yusuke Inoue, et al.
Published: (2014-10-01)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
by: Sungmin Woo, et al.
Published: (2020-09-01)

Ability of 68Ga‐PSMA PET/CT SUVmax to differentiate ISUP GG2 from GG3 in intermediate‐risk prostate cancer: A single‐center retrospective study of 147 patients
by: Nuo Yi, et al.
Published: (2023-03-01)

A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients
by: Mike Allan Mortensen, et al.
Published: (2018-12-01)

Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology
by: Marion Bankstahl, et al.
Published: (2017-12-01)